The ubiquitin-proteasome system in neurodegenerative diseases: precipitating factor, yet part of the solution

Acs, 2011, The AAA-ATPase VCP/p97 promotes 53BP1 recruitment by removing L3MBTL1 from DNA double-strand breaks, Nat. Struct. Mol. Biol, 18, 1345, 10.1038/nsmb.2188

Adachi, 2007, CHIP overexpression reduces mutant androgen receptor protein and ameliorates phenotypes of the spinal and bulbar muscular atrophy transgenic mouse model, J. Neurosci, 27, 5115, 10.1523/JNEUROSCI.1242-07.2007

Almeida, 2006, Beta-amyloid accumulation impairs multivesicular body sorting by inhibiting the ubiquitin-proteasome system, J. Neurosci, 26, 4277, 10.1523/JNEUROSCI.5078-05.2006

Al-Ramahi, 2006, CHIP protects from the neurotoxicity of expanded and wild-type ataxin-1 and promotes their ubiquitination and degradation, J. Biol. Chem, 281, 26714, 10.1074/jbc.M601603200

Aquilano, 2003, Proteasome activation and nNOS down-regulation in neuroblastoma cells expressing a Cu,Zn superoxide dismutase mutant involved in familial ALS, J. Neurochem, 85, 1324, 10.1046/j.1471-4159.2003.01783.x

Arrasate, 2004, Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death, Nature, 431, 805, 10.1038/nature02998

Ashrafi, 2013, The pathways of mitophagy for quality control and clearance of mitochondria, Cell Death Differ, 20, 31, 10.1038/cdd.2012.81

Aso, 2012, Amyloid generation and dysfunctional immunoproteasome activation with disease progression in animal model of familial Alzheimer's disease, Brain Pathol, 22, 636, 10.1111/j.1750-3639.2011.00560.x

Bailey, 2002, Molecular chaperones enhance the degradation of expanded polyglutamine repeat androgen receptor in a cellular model of spinal and bulbar muscular atrophy, Hum. Mol. Genet, 11, 515, 10.1093/hmg/11.5.515

Bartolome, 2013, Pathogenic VCP mutations induce mitochondrial uncoupling and reduced ATP levels, Neuron, 78, 57, 10.1016/j.neuron.2013.02.028

Bedford, 2010, Assembly, structure, and function of the 26S proteasome, Trends Cell Biol, 20, 391, 10.1016/j.tcb.2010.03.007

Bence, 2001, Impairment of the ubiquitin-proteasome system by protein aggregation, Science, 292, 1552, 10.1126/science.292.5521.1552

Bennett, 2005, Global impairment of the ubiquitin-proteasome system by nuclear or cytoplasmic protein aggregates precedes inclusion body formation, Mol. Cell, 17, 351, 10.1016/j.molcel.2004.12.021

Bennett, 2007, Global changes to the ubiquitin system in Huntington's disease, Nature, 448, 704, 10.1038/nature06022

Bennett, 1999, Degradation of alpha-synuclein by proteasome, J. Biol. Chem, 274, 33855, 10.1074/jbc.274.48.33855

Bertram, 2005, Family-based association between Alzheimer's disease and variants in UBQLN1, N. Engl. J. Med, 352, 884, 10.1056/NEJMoa042765

Bett, 2009, The ubiquitin-proteasome reporter GFPu does not accumulate in neurons of the R6/2 transgenic mouse model of Huntington's disease, PLoS ONE, 4, e5128, 10.1371/journal.pone.0005128

Bett, 2006, Proteasome impairment does not contribute to pathogenesis in R6/2 Huntington's disease mice: exclusion of proteasome activator REGgamma as a therapeutic target, Hum. Mol. Genet, 15, 33, 10.1093/hmg/ddi423

Bhattacharyya, 2014, Regulated protein turnover: snapshots of the proteasome in action, Nat. Rev. Mol. Cell Biol, 15, 122, 10.1038/nrm3741

Bhutani, 2007, Puromycin-sensitive aminopeptidase is the major peptidase responsible for digesting polyglutamine sequences released by proteasomes during protein degradation, EMBO J, 26, 1385, 10.1038/sj.emboj.7601592

Bodner, 2006, Pharmacological promotion of inclusion formation: a therapeutic approach for Huntington's and Parkinson's diseases, Proc. Natl. Acad. Sci. U.S.A, 103, 4246, 10.1073/pnas.0511256103

Bonini, 2005, Silencing polyglutamine degeneration with RNAi, Neuron, 48, 715, 10.1016/j.neuron.2005.11.008

Bove, 2006, Proteasome inhibition and Parkinson's disease modeling, Ann. Neurol, 60, 260, 10.1002/ana.20937

Bowman, 2005, Neuronal dysfunction in a polyglutamine disease model occurs in the absence of ubiquitin-proteasome system impairment and inversely correlates with the degree of nuclear inclusion formation, Hum. Mol. Genet, 20, 20, 10.1093/hmg/ddi064

Buchan, 2013, Eukaryotic stress granules are cleared by autophagy and Cdc48/VCP function, Cell, 153, 1461, 10.1016/j.cell.2013.05.037

Buckley, 2014, Small-molecule control of intracellular protein levels through modulation of the ubiquitin proteasome system, Angew. Chem. Int. Ed Engl, 53, 2312, 10.1002/anie.201307761

Burnett, 2005, The polyglutamine neurodegenerative protein ataxin 3 regulates aggresome formation, Proc. Natl. Acad. Sci. U.S.A, 102, 4330, 10.1073/pnas.0407252102

Burnett, 2003, The polyglutamine neurodegenerative protein ataxin-3 binds polyubiquitylated proteins and has ubiquitin protease activity, Hum. Mol. Genet, 12, 3195, 10.1093/hmg/ddg344

Carrell, 1997, Conformational disease, Lancet, 350, 134, 10.1016/S0140-6736(97)02073-4

Casciati, 2002, Oxidative modulation of nuclear factor-kappaB in human cells expressing mutant fALS-typical superoxide dismutases, J. Neurochem, 83, 1019, 10.1046/j.1471-4159.2002.01232.x

Caussinus, 2012, Fluorescent fusion protein knockout mediated by anti-GFP nanobody, Nat. Struct. Mol. Biol, 19, 117, 10.1038/nsmb.2180

Chen, 2006, Proteasome dysfunction in aged human alpha-synuclein transgenic mice, Neurobiol. Dis, 23, 120, 10.1016/j.nbd.2006.02.004

Cheroni, 2009, Functional alterations of the ubiquitin-proteasome system in motor neurons of a mouse model of familial amyotrophic lateral sclerosis, Hum. Mol. Genet, 18, 82, 10.1093/hmg/ddn319

Chondrogianni, 2007, Overexpression of hUMP1/POMP proteasome accessory protein enhances proteasome-mediated antioxidant defence, Exp. Gerontol, 42, 899, 10.1016/j.exger.2007.01.012

Chondrogianni, 2005, Overexpression of proteasome beta5 assembled subunit increases the amount of proteasome and confers ameliorated response to oxidative stress and higher survival rates, J. Biol. Chem, 280, 11840, 10.1074/jbc.M413007200

Ciechanover, 2003, The ubiquitin proteasome system in neuordegenerative diseases: sometimes the chicken, sometimes the egg, Neuron, 40, 427, 10.1016/S0896-6273(03)00606-8

Clark, 2006, Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin, Nature, 441, 1162, 10.1038/nature04779

Crippa, 2010, The small heat shock protein B8 (HspB8) promotes autophagic removal of misfolded proteins involved in amyotrophic lateral sclerosis (ALS), Hum. Mol. Genet, 19, 3440, 10.1093/hmg/ddq257

Cummings, 1998, Chaperone suppression of aggregation and altered subcellular proteasome localization imply protein misfolding in SCA1, Nat. Genet, 19, 148, 10.1038/502

Cummings, 1999, Mutation of the E6-AP ubiquitin ligase reduces nuclear inclusion frequency while accelerating polyglutamine-induced pathology in SCA1 mice, Neuron, 24, 879, 10.1016/S0896-6273(00)81035-1

Czirr, 2012, The immunology of neurodegeneration, J. Clin. Invest, 122, 1156, 10.1172/JCI58656

Dantuma, 2012, Growing sphere of influence: Cdc48/p97 orchestrates ubiquitin-dependent extraction from chromatin, Trends Cell Biol, 22, 483, 10.1016/j.tcb.2012.06.003

Dantuma, 2000, Short-lived green fluorescent proteins for quantifying ubiquitin/proteasome-dependent proteolysis in living cells, Nat. Biotechnol, 18, 538, 10.1038/75406

Deriziotis, 2011, Misfolded PrP impairs the UPS by interaction with the 20S proteasome and inhibition of substrate entry, EMBO J, 30, 3065, 10.1038/emboj.2011.224